Inventor · Carlsbad, CA, US

Mohammad Ahmadian

24Patents
8h-index
32Co-inventors
71Inventor score

Filing activity: Oct 18, 2007 → Aug 11, 2020

Most-cited inventions

PatentTitleAreaCited byStatus
US8741867B2 Retinoid-liposomes for treating fibrosis Chemistry; Metallurgy 31 Active
US8664376B2 Retinoid-liposomes for enhancing modulation of HSP47 expression Chemistry; Metallurgy 26 Active
US9011903B2 Cationic lipids for therapeutic agent delivery formulations Chemistry; Metallurgy 22 Active
US9456984B2 Method for treating fibrosis using siRNA and a retinoid-lipid drug carrier Chemistry; Metallurgy 10 Active
US9242001B2 Cationic lipids for therapeutic agent delivery formulations Chemistry; Metallurgy 10 Active
US9393315B2 Compounds for targeting drug delivery and enhancing siRNA activity Emerging Cross-Sectional Technologies 9 Active
US10047111B2 RNA interference agents for GST-PI gene modulation Chemistry; Metallurgy 9 Active
US9963424B2 Cationic lipids for therapeutic agent delivery formulations Chemistry; Metallurgy 8 Active
US9308267B2 Lipids for therapeutic agent delivery formulations Emerging Cross-Sectional Technologies 6 Active
US10047110B2 RNA agents for GST-Pi gene modulation Chemistry; Metallurgy 5 Active
US10441659B2 Lipids for therapeutic agent delivery formulations Emerging Cross-Sectional Technologies 3 Active
US10100004B2 Compounds for targeting drug delivery and enhancing siRNA activity Emerging Cross-Sectional Technologies 3 Active
US10196637B2 Retinoid-lipid drug carrier Chemistry; Metallurgy 3 Active
US10000447B2 Compounds for targeting drug delivery and enhancing siRNA activity Emerging Cross-Sectional Technologies 2 Active
US11084779B2 Cationic lipids for therapeutic agent delivery formulations Chemistry; Metallurgy 2 Active
US10195145B2 Method for treating fibrosis using siRNA and a retinoid-lipid drug carrier Chemistry; Metallurgy 2 Active
US10669229B2 Compounds for targeting drug delivery and enhancing siRNA activity Emerging Cross-Sectional Technologies 0 Active
US9074205B2 Nicked or gapped nucleic acid molecules and uses thereof Chemistry; Metallurgy 0 Active
US11103583B2 Lipids for therapeutic agent delivery formulations Emerging Cross-Sectional Technologies 0 Active
US8940857B2 Methods and compositions for enhancing delivery of double-stranded RNA or a double-stranded hybrid nucleic acid to regulate gene expression in mammalian cells Chemistry; Metallurgy 0 Active
USRE49431E1 RNA interference agents for GST-PI gene modulation General 0 Active
US10961181B2 Cationic lipids for therapeutic agent delivery formulations General 0 Revoked
US10532975B2 Cationic lipids for therapeutic agent delivery formulations Chemistry; Metallurgy 0 Active
US11045488B2 RNA interference agents for GST-π gene modulation Chemistry; Metallurgy 0 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.